{"id":"W4406716329","doi":"10.1016/s1474-4422(24)00475-7","title":"Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Heart Institute; University of Ottawa; University of Calgary; University of British Columbia; University of Toronto; Population Health Research Institute","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences; Medtronic; Heart and Stroke Foundation of Canada; Bristol-Myers Squibb Foundation","keywords":"Atrial fibrillation; Medicine; Aspirin; Stroke (engine); Apixaban; Subclinical infection; Subgroup analysis; Cardiology; Internal medicine; Randomized controlled trial; Ischaemic stroke; Meta-analysis; Warfarin; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008768187,0.000112773,0.001198024,0.0002158867,0.00002761501,0.000003265215,0.00009115791,0.00009136003,0.00002343705],"category_scores_gemma":[0.0005269804,0.00005954429,0.0005081292,0.0003054421,0.0001250411,0.00002964536,0.00002566254,0.0001158601,1.241164e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003268463,"about_ca_system_score_gemma":0.0001484647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002737718,"about_ca_topic_score_gemma":0.0009048097,"domain_scores_codex":[0.9984515,0.0004189151,0.0006192281,0.0002020643,0.0001590489,0.0001492207],"domain_scores_gemma":[0.9968221,0.002454697,0.0003750619,0.000276539,0.00005287075,0.0000187623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8935478,0.00001232819,0.1022276,0.00005328502,0.001234449,5.355871e-7,0.0001641433,0.001629849,0.0003128059,0.0002804619,0.0001233399,0.000413449],"study_design_scores_gemma":[0.7844695,0.002361912,0.1922432,0.00001581439,0.005410233,6.529366e-7,0.00002705398,0.01321994,0.00001800559,0.00001999833,0.002157841,0.00005585182],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898201,0.0002289448,0.0005242684,0.004628375,0.0006128862,0.003981382,0.00001144206,0.00001159487,0.000181039],"genre_scores_gemma":[0.9982049,0.00008137099,0.00004201426,0.0001257584,0.0003749045,0.00001923169,0.00001652629,0.000006998167,0.001128268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1090783,"threshold_uncertainty_score":0.2428146,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07440965477632437,"score_gpt":0.3541185238956161,"score_spread":0.2797088691192917,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}